Results 221 to 230 of about 172,168 (267)
Some of the next articles are maybe not open access.

Targeting of BCR-ABL: Lessons learned from BCR-ABL inhibition.

Cellular and molecular biology (Noisy-le-Grand, France), 2017
In 1960 researchers reported that balanced translocation between chromosomes 22 and 9 resulted in the generation of Philadelphia chromosome. This breakthrough revolutionized our knowledge related to leukemia biology and contemporary studies revealed that chromosomal translocation resulted in the fusion between the 5' segment of BCR gene and 3' segment ...
X, Lin   +10 more
openaire   +1 more source

?????????????? ??'?????????? ???????????? ???????? bcr/abl ?????? ???????????????? ???????????????????????????? ?????????????? ?? ???????????????????????????????? ????????????????????

2019
???????????????????????? 3???8 ?????????????? ???????????????????? ???????? bcr/abl ?????????????????? ?????????????? ?????????????? ??'?????????? ???????????? (108 ??????????????????????) ?? ?????????????? ???? ?????????????? ?????????????????????????? ???????????? ?? ???????????????? ?? ?????????????? M-bcr. ???????????????????????????? ???????? ?????
openaire   +3 more sources

The Role of MYC in Transformation by BCR-ABL

Leukemia & Lymphoma, 1993
The BCR-ABL gene plays a central role in the pathogenesis of chronic myelogenous leukemia. Despite a detailed understanding of the regions of BCR and ABL required for transformation by BCR-ABL, little is known about the signalling pathway by which BCR-ABL causes transformation. The nuclear oncogene c-myc plays a critical role in BCR-ABL transformation.
openaire   +2 more sources

Malignant transformation by abl and BCR/ABL

1993
Activated abl oncogenes have been implicated in causing pre-B lymphoma in mice via Abelson murine leukemia virus, fibrosarcoma in cats via Hardy-Zuckerman feline sarcoma virus II, and, through the Philadelphia chromosome, are linked with the myeloproliferative syndrome chronic myelogenous leukemia and with acute lymphoid and myeloid leukemia in humans.
openaire   +2 more sources

The chimeric BCR-ABL gene.

Bailliere's clinical haematology, 1997
The 1982 discovery that in chronic myeloid leukaemia (CML) the ABL proto-oncogene is translocated to the BCR gene located on chromosome 22 initiated many studies on the structural organization and function of these genes. The nucleotide sequence of the entire BCR and major parts of the ABL gene has now been determined.
J, Groffen, N, Heisterkamp
openaire   +1 more source

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features

Annals of Hematology, 2016
N. Neuendorff   +3 more
semanticscholar   +1 more source

???????????????????? ???????????????????????? BCR/ABL ?????? ????????????????????-???????????????????????? ?????????????? ???????????????????? ?????????????????? ?????????????? ???????????????????????????? in situ ????????????????????????

2017
We report the results of BCR/ABL translocation analysis on interphase leukemic cells of 33 acute myeloid leukemia (AML) patients by fluorescence in situ hybridization. Of these, there were 13 persons exposed to ionizing radiation due to the Chernobyl accident with radiation-associated AML and 20 patients with spontaneous disease.
openaire   +1 more source

bcr—abl

Current Opinion in Oncology, 1992
openaire   +1 more source

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.

Cancer Research, 2005
T. O'Hare   +10 more
semanticscholar   +1 more source

Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: A review.

Critical reviews in oncology/hematology, 2015
Ke Yang, Li-Wu Fu
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy